Targeting Immune Biology Beyond the Tumor Cell: Unlocking LFA-1 for Radiopharmaceutical Development
9:30 am - Wednesday 24th February 2027
- Explore LFA-1 on leukocytes as an emerging target to move beyond conventional tumor-cell receptor expression
- Harness innate immune biology and leukocyte activity within the tumor environment to identify new opportunities for targeted imaging and therapy
- Translate LFA-1-targeted ligands from imaging into therapeutic applications, leveraging early clinical validation to inform next-generation development
Novel Target
